Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
MDU Resources Group | MDU | Nov 25, 2024 | 20.13 | +0.95 |
MDxHealth | MDXH | Nov 25, 2024 | 1.87 | -0.53 |
Medalist Diversified REIT | MDRR | Nov 25, 2024 | 12.31 | +0.70 |
Medalist Diversified REIT A Pref | MDRRP | Nov 25, 2024 | 25.57 | +1.07 |
Medallion Bank F Pref | MBNKP | Nov 25, 2024 | 25.70 | 0.00 |
Medallion Financial | MFIN | Nov 25, 2024 | 9.46 | -1.05 |
MediaAlpha | MAX | Nov 25, 2024 | 12.97 | +1.89 |
Mediaco A | MDIA | Nov 25, 2024 | 1.31 | -0.38 |
Medical Properties Trust | MPW | Nov 25, 2024 | 4.48 | +3.94 |
MediciNova | MNOV | Nov 25, 2024 | 2.05 | -3.76 |
Medicus Pharma | MDCX | Nov 25, 2024 | 2.07 | 0.00 |
Medifast | MED | Nov 25, 2024 | 18.62 | +1.14 |
MEDIROM Healthcare Technologies ADR | MRM | Nov 25, 2024 | 2.99 | +10.42 |
MediWound | MDWD | Nov 25, 2024 | 17.33 | +5.16 |
Mednax | MD | Nov 25, 2024 | 14.76 | -1.34 |
Medpace | MEDP | Nov 25, 2024 | 337.82 | +0.02 |
Medtronic | MDT | Nov 25, 2024 | 85.75 | -0.53 |
Mega Matrix | MPU | Nov 25, 2024 | 1.55 | -7.19 |
Megacap 300 Growth Index ETF Vanguard | MGK | Nov 25, 2024 | 335.90 | +0.00 |
Megacap 300 Index ETF Vanguard | MGC | Nov 25, 2024 | 214.56 | +0.26 |
Megacap 300 Value Index ETF Vanguard | MGV | Nov 25, 2024 | 132.94 | +0.51 |
MEI Pharma | MEIP | Nov 25, 2024 | 2.76 | -0.72 |
Meihua International Medical Technologies | MHUA | Nov 25, 2024 | 0.59 | -17.95 |
MeiraGTx Holdings | MGTX | Nov 25, 2024 | 6.33 | +6.75 |
Meiwu Technology | WNW | Nov 25, 2024 | 0.84 | +1.14 |
Melar Acquisition I | MACIU | Nov 25, 2024 | 10.14 | 0.00 |
Melar Acquisition I | MACI | Nov 25, 2024 | 10.05 | +0.16 |
Melco Resorts & Entertainment ADR | MLCO | Nov 25, 2024 | 6.07 | +2.02 |
MercadoLibre | MELI | Nov 25, 2024 | 2 099.95 | +4.74 |
Mercantile Bank | MBWM | Nov 25, 2024 | 51.14 | +1.49 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.